The drugs would still not be FDA-approved, and the FDA would still not vouch for their safety or effectiveness. Koehl Robinson, founder and CEO of CeliaRX, a telehealth company that sells injectable and topical peptides compounded by a 503A pharmacy partner (not the ones on the FDAs potential unbanned list), says that if the peptides are reclassified, it would likely open up new possibilities for her customers, as well as lead to more clarity and less confusion
Researchers are encouraged to review available scientific literature and conduct independent evaluations using appropriate laboratory protocols
You should treat any use as experimental and risky until researchers complete larger, longer-term trials
What vitamin deficiency can cause nerve pain
Please contact us to schedule your injection
It is not approved for therapeutic use and is available solely for experimental and laboratory research